Form D — Ensho Therapeutics, Inc.
0002032849-25-000003 · filed 2025-09-12
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $22,500,000
- Total sold
- $22,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ensho Therapeutics, Inc.
- CIK
- 2032849
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 50 Tice Boulevard
Woodcliff Lake, NJ 07677 - Phone
- 973-475-8970
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Neena Bitritto-Garg · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
Bittoo Kanwar · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
James Whitney · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
Emily Weng · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
Matthew McKevitt · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
Danielle Fry · Executive OfficerMorris Plains, NJ Find on LinkedIn ↗
-
Arash Rassoulpour · DirectorMorris Plains, NJ Find on LinkedIn ↗
-
Carlos Solorzano · DirectorMorris Plains, NJ Find on LinkedIn ↗
-
Eric Pham · DirectorMorris Plains, NJ Find on LinkedIn ↗
View original on SEC EDGAR.